ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.
Pathology and Molecular Biology
Featured medwireNews
BRCA1/2 Germline Mutations Linked To Guideline Nonconcordant Treatment
Anastrozole Reduces Postmenopausal Breast Cancer Risk Over Long Term
Ipilimumab ‘Feasible’ Option For Locally Advanced Cervical Cancer
Clinically Relevant Genomic Alterations Identified In Two-Fifths of Soft-Tissue Sarcomas
Meeting resources
Role of pathology
Presenter: M. Milione, IT
Session: Session 1 - Terminology, diagnosis, characterization and staging
Resources:
Slides
Webcast
LBA2 - Impact of RNA expression signatures and tumor infiltrating lymphocytes (TILs) for pathological complete response (pCR) and survival after 12 week de-escalated neoadjuvant pertuzumab + trastuzumab ± paclitaxel in the WSG-HER2+/HR- ADAPT trial.
Presenter: Monika Graeser
Session: Proffered Paper session 2
Resources:
Abstract
Slides
Webcast
Molecular testing algorithms for metastatic BC
Presenter: Federico Rojo
Session: Testing recommendation in breast cancer
Resources:
Slides
Webcast
Immunohistochemistry: The new IHC “low” categories (ER, HER2⋯.) and androgen receptor testing
Presenter: Carsten Denkert
Session: Testing recommendation in breast cancer
Resources:
Slides
Webcast
Understanding CRC Biology: MSI, BRAF, RAS, Immunoscore, and Others. What Are the Drivers of the Malignancy, and What Do We Have to Understand?
Presenter: I. Nagtegaal, NL
Session: SESSION 1 - Early colon cancer
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.